Scientist, R&D Chemistry, Peptidomimetic Purification
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a lab-centric peptide purification chemist to join the R&D Chemistry group. In this role, you will play a key part in Regeneron's peptidomimetic antibody-conjugate drug discovery capabilities, enabling seamless combination with the company's existing expertise in biologics and novel genetic medicines. You will primarily drive the high-throughput (HT) purification of peptidomimetic payloads and linker payloads (LPs) for antibody conjugate drug therapeutics across diverse research areas, with other responsibilities potentially including purification of small molecules/LPs and antibody conjugates, as well as the development of automation processes, equipment, and workflows for all purifications. The R&D Chemistry team is primarily composed of synthetic organic, peptidomimetic, medicinal chemistry, and bioconjugation scientists who work in a highly collaborative environment with other technology, biology, and therapeutic area groups.
Job description
Build our future together
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a lab-centric peptide purification chemist to join the R&D Chemistry group. In this role, you will play a key part in Regeneron's peptidomimetic antibody-conjugate drug discovery capabilities, enabling seamless combination with the company's existing expertise in biologics and novel genetic medicines. You will primarily drive the high-throughput (HT) purification of peptidomimetic payloads and linker payloads (LPs) for antibody conjugate drug therapeutics across diverse research areas, with other responsibilities potentially including purification of small molecules/LPs and antibody conjugates, as well as the development of automation processes, equipment, and workflows for all purifications. The R&D Chemistry team is primarily composed of synthetic organic, peptidomimetic, medicinal chemistry, and bioconjugation scientists who work in a highly collaborative environment with other technology, biology, and therapeutic area groups.
Discover your role
- Actively participate and collaborate in the day-to-day activities of the R&D Chemistry peptidomimetic and small molecule purification team
- Perform mass-triggered reverse-phase preparative HPLC-MS purification and analytical LC-MS characterization of novel peptidomimetic and small molecule drug modalities using modern purification/detection instrumentation and techniques
- Troubleshoot and optimize peptide and small molecule purification methods to enable high throughput purification, isolation, and characterization
- Execute and optimize purification workflows involving crude reaction mixture prep, fraction collection, tracking, isolation, and final product delivery, with an eye on improving throughput, consistency, and recovery
- Identify new strategies and technologies for peptidomimetic and small molecule purification to improve on existing Regeneron techniques
- Actively participate in departmental, cross-functional, leadership, and external meetings to contribute expertise and represent the vision of the R&D Chemistry Peptidomimetic purification team
- Interact broadly and collaboratively with other Regeneron groups, forging relationships and active collaborations
- Bring passion and enthusiasm for the promise of peptidomimetic conjugated, antibody-targeted therapeutics and how peptide purification can enable their generation
- Apply and combine traditional methods and novel technologies to develop solutions for purification
- Work comfortably in a cross-functional role, excelling as part of a diverse team
- Contribute meaningfully to an organizational culture that supports growth and development of its people and capabilities to drive the Regeneron pipeline forward
- Approach work with a modality-agnostic mindset, letting the data determine the best course forward
This role requires
- Bachelor's or Master's degree in chromatography/analytical characterization of peptides/peptidomimetics and small molecules
- Extensive hands-on experience with HPLC purification/characterization and method troubleshooting of peptidomimetics and small molecules
- Extensive experience running modern purification/characterization LC-MS equipment and instrumentation (e.g., Waters and/or Agilent preparative purification and analytical systems)
- Minimum of 5-10 years of industry experience
- Track record of success in the field of peptidomimetics purification/characterization
- Experience with small molecules purification/characterization desired
- Ability to work collaboratively with both internal and external organizations (e.g., CROs)
Requirements
- Bachelor's or Master's degree in chromatography/analytical characterization of peptides/peptidomimetics and small molecules
- Extensive hands-on experience with HPLC purification/characterization and method troubleshooting of peptidomimetics and small molecules
- Extensive experience running modern purification/characterization LC-MS equipment and instrumentation (e.g., Waters and/or Agilent preparative purification and analytical systems)
- Minimum of 5-10 years of industry experience
- Track record of success in the field of peptidomimetics purification/characterization
- Experience with small molecules purification/characterization desired
- Ability to work collaboratively with both internal and external organizations (e.g., CROs)
Benefits
- Annual Bonuses
- Incentive Plans
- Equity Awards
- Pension or Retirement Benefits
- 401(k) Matching
- Health and Wellness Programs
- Fitness Centers
- Medical, Dental & Vision
- Life and Disability Insurance
- Paid Time Off
- Family Support Benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.